Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioventus (BVS) Total Non-Current Liabilities (2020 - 2025)

Historic Total Non-Current Liabilities for Bioventus (BVS) over the last 6 years, with Q3 2025 value amounting to $473.9 million.

  • Bioventus' Total Non-Current Liabilities fell 1484.98% to $473.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $473.9 million, marking a year-over-year decrease of 1484.98%. This contributed to the annual value of $519.2 million for FY2024, which is 758.34% down from last year.
  • Latest data reveals that Bioventus reported Total Non-Current Liabilities of $473.9 million as of Q3 2025, which was down 1484.98% from $484.2 million recorded in Q2 2025.
  • Bioventus' Total Non-Current Liabilities' 5-year high stood at $937.6 million during Q4 2022, with a 5-year trough of $392.8 million in Q2 2021.
  • Moreover, its 5-year median value for Total Non-Current Liabilities was $556.5 million (2024), whereas its average is $574.8 million.
  • Per our database at Business Quant, Bioventus' Total Non-Current Liabilities surged by 13817.82% in 2022 and then crashed by 4090.09% in 2023.
  • Quarter analysis of 5 years shows Bioventus' Total Non-Current Liabilities stood at $596.5 million in 2021, then skyrocketed by 57.19% to $937.6 million in 2022, then tumbled by 40.08% to $561.9 million in 2023, then decreased by 7.58% to $519.2 million in 2024, then dropped by 8.74% to $473.9 million in 2025.
  • Its Total Non-Current Liabilities stands at $473.9 million for Q3 2025, versus $484.2 million for Q2 2025 and $484.0 million for Q1 2025.